Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964–2003 followed up to the end of 2006

References

• Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Olafsdóttir E, . NORDCAN: Cancer incidence, mortality, and prevalence in the Nordic countries. Version 3.3. http://www.ancr.nu. Association of Nordic Cancer Registries, Danish Cancer Society; 2008.
   Google Scholar
• Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1987;1(8544):1247–9.
   PubMedGoogle Scholar
• Hankinson SE, Danforth KN. Ovarian cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 1013–26.
   Google Scholar
• Lacey JVJ, Colditz GA, Schottenfeld D. Exogenous hormones. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 468–88.
   Google Scholar
• Cook LS, Weiss NS, Doherty JA, Chen C. Endometrial cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 1027–43.
   Google Scholar
• Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345–89.
   PubMed Web of Science ®Google Scholar
• Schiffman MH, Hildesheim A. Cervical cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 1044–67.
   Google Scholar
• Madeleine MM, Daling JR. Cancers of the vulva and vagina. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 1068–74.
   Google Scholar
• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009; 45: 931–91.
   PubMed Web of Science ®Google Scholar
• Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, . Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl 1995; 49: 1–161.
   PubMedGoogle Scholar
• Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol 2010.
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307–16.
   PubMed Web of Science ®Google Scholar
• Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. Magnus K. Trends in cancer incidence causes and practical implications. Washington D.C.: Hemisphere Publishing Corporation; 1982. 279–92.
   Google Scholar
• International Agency for Research on Cancer. Cervix cancer screening. Lyon: IARC Press; 2004.
   Google Scholar
• Sigurdsson K, Sigvaldason H. Effectiveness of cervical cancer screening in Iceland, 1964–2002: A study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand 2006; 85: 343–9.
   PubMed Web of Science ®Google Scholar
• Bielska-Lasota M, Inghelmann R, van de Poll-Franse L, Capocaccia R. Trends in cervical cancer survival in Europe, 1983–1994: A population-based study. Gynecol Oncol 2007; 105: 609–19.
   PubMed Web of Science ®Google Scholar
• Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, . Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005; 14: 677–86.
   PubMed Web of Science ®Google Scholar
• Saxen E, Hakama M. Cancer illness in Finland with a note on the effects of age adjustment and early diagnosis. Ann Med Exp Biol Fenn 1964;42(Suppl 2):1–28.
   PubMedGoogle Scholar
• Eide TJ. Cancer of the uterine cervix in Norway by histologic type, 1970–84. J Natl Cancer Inst 1987; 79: 199–205.
   PubMedGoogle Scholar
• Bjørge T, Thoresen SO, Skare GB. Incidence, survival and mortality in cervical cancer in Norway, 1956–1990. Eur J Cancer 1993;29A:2291–7.
   PubMedGoogle Scholar
• Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell AH, Jones WB, . Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 1995;76(10 Suppl):1948–55.
   PubMedGoogle Scholar
• Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer 2003; 89: 834–9.
   PubMed Web of Science ®Google Scholar
• Pukkala E, Malila N, Hakama M. Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Acta Oncol 2010; 49: 180–4.
   PubMed Web of Science ®Google Scholar
• Armannsdóttir B, Tryggvadóttir L, Jónasson JG, Olafsdóttir EJ, Guðmundsson1 JA. [Use of hormone replacement therapy by Icelandic women in the years 1996–2001]. Laeknabladid 2004; 90: 471–7.
   PubMedGoogle Scholar
• Health Statistics in the Nordic Countries 2006. Vol 82. Copenhagen, Denmark: NOMESCO Nordic Medical Statistical Committee; 2008. (http://nomesco-eng.nom-nos.dk/filer/publikationer/Helse%202006.pdf, Table 3.7.9)
   Google Scholar
• Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: Scientific review. JAMA 2002; 288: 872–81.
   PubMed Web of Science ®Google Scholar
• Kitchener HC. Survival from endometrial cancer in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S68–9.
   PubMedGoogle Scholar
• Yang L, Klint A, Lambe M, Bellocco R, Riman T, Bergfeldt K, . Predictors of ovarian cancer survival: A population-based prospective study in Sweden. Int J Cancer 2008; 123: 672–9.
   PubMedGoogle Scholar
• Hannibal CG, Cortes R, Engholm G, Kjaer SK. Survival of ovarian cancer patients in Denmark: Excess mortality risk analysis of five-year relative survival in the period 1978–2002. Acta Obstet Gynecol Scand 2008;87: 1353–60.
   PubMed Web of Science ®Google Scholar
• Ottesen B, Iversen MG, Kehlet H. [Surgical treatment for ovarian cancer in Denmark 2004–2007]. Ugeskr Laeger 2009; 171: 217–20.
   PubMedGoogle Scholar
• Kitchener HC. Survival from cancer of the ovary in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):S73–4.
   PubMedGoogle Scholar
• Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in ovarian cancer. Acta Oncol 2001; 40: 340–60.
   PubMed Web of Science ®Google Scholar
• Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305–13.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009; 48: 27–33.
   PubMed Web of Science ®Google Scholar